Literature DB >> 23152531

Cyclophilin inhibitors block arterivirus replication by interfering with viral RNA synthesis.

Adriaan H de Wilde1, Yanhua Li, Yvonne van der Meer, Grégoire Vuagniaux, Robert Lysek, Ying Fang, Eric J Snijder, Martijn J van Hemert.   

Abstract

Virus replication strongly depends on cellular factors, in particular, on host proteins. Here we report that the replication of the arteriviruses equine arteritis virus (EAV) and porcine reproductive and respiratory syndrome virus (PRRSV) is strongly affected by low-micromolar concentrations of cyclosporine A (CsA), an inhibitor of members of the cyclophilin (Cyp) family. In infected cells, the expression of a green fluorescent protein (GFP) reporter gene inserted into the PRRSV genome was inhibited with a half-maximal inhibitory concentration (IC(50)) of 5.2 μM, whereas the GFP expression of an EAV-GFP reporter virus was inhibited with an IC(50) of 0.95 μM. Debio-064, a CsA analog that lacks its undesirable immunosuppressive properties, inhibited EAV replication with an IC(50) that was 3-fold lower than that of CsA, whereas PRRSV-GFP replication was inhibited with an IC(50) similar to that of CsA. The addition of 4 μM CsA after infection prevented viral RNA and protein synthesis in EAV-infected cells, and CsA treatment resulted in a 2.5- to 4-log-unit reduction of PRRSV or EAV infectious progeny. A complete block of EAV RNA synthesis was also observed in an in vitro assay using isolated viral replication structures. The small interfering RNA-mediated knockdown of Cyp family members revealed that EAV replication strongly depends on the expression of CypA but not CypB. Furthermore, upon fractionation of intracellular membranes in density gradients, CypA was found to cosediment with membranous EAV replication structures, which could be prevented by CsA treatment. This suggests that CypA is an essential component of the viral RNA-synthesizing machinery.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23152531      PMCID: PMC3554155          DOI: 10.1128/JVI.02078-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

Review 1.  Nidovirus transcription: how to make sense...?

Authors:  Alexander O Pasternak; Willy J M Spaan; Eric J Snijder
Journal:  J Gen Virol       Date:  2006-06       Impact factor: 3.891

2.  Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation.

Authors:  Wataru Kamitani; Krishna Narayanan; Cheng Huang; Kumari Lokugamage; Tetsuro Ikegami; Naoto Ito; Hideyuki Kubo; Shinji Makino
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-15       Impact factor: 11.205

3.  Integrity of the early secretory pathway promotes, but is not required for, severe acute respiratory syndrome coronavirus RNA synthesis and virus-induced remodeling of endoplasmic reticulum membranes.

Authors:  Kèvin Knoops; Cindy Swett-Tapia; Sjoerd H E van den Worm; Aartjan J W Te Velthuis; Abraham J Koster; A Mieke Mommaas; Eric J Snijder; Marjolein Kikkert
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

4.  An infectious recombinant equine arteritis virus expressing green fluorescent protein from its replicase gene.

Authors:  Erwin van den Born; Clara C Posthuma; Kèvin Knoops; Eric J Snijder
Journal:  J Gen Virol       Date:  2007-04       Impact factor: 3.891

5.  Nucleocapsid protein expression facilitates coronavirus replication.

Authors:  Barbara Schelle; Nadja Karl; Burkhard Ludewig; Stuart G Siddell; Volker Thiel
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

6.  Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase.

Authors:  Koichi Watashi; Naoto Ishii; Makoto Hijikata; Daisuke Inoue; Takayuki Murata; Yusuke Miyanari; Kunitada Shimotohno
Journal:  Mol Cell       Date:  2005-07-01       Impact factor: 17.970

7.  Discovery of a potent peptidic cyclophilin A inhibitor Trp-Gly-Pro.

Authors:  Xiaodong Pang; Mingjun Zhang; Linxiang Zhou; Fang Xie; Hong Lu; Wu He; Shibo Jiang; Long Yu; Xinyi Zhang
Journal:  Eur J Med Chem       Date:  2011-02-22       Impact factor: 6.514

8.  The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naïve hepatitis C patients.

Authors:  Robert Flisiak; Saya V Feinman; Maciej Jablkowski; Andrzej Horban; Wieslaw Kryczka; Małgorzata Pawlowska; Jenny E Heathcote; Giuseppe Mazzella; Carmen Vandelli; Valérie Nicolas-Métral; Pierre Grosgurin; Jorge S Liz; Pietro Scalfaro; Hervé Porchet; Raf Crabbé
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

9.  Cyclophilin A interacts with domain II of hepatitis C virus NS5A and stimulates RNA binding in an isomerase-dependent manner.

Authors:  Toshana L Foster; Philippe Gallay; Nicola J Stonehouse; Mark Harris
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

Review 10.  Nidovirales: evolving the largest RNA virus genome.

Authors:  Alexander E Gorbalenya; Luis Enjuanes; John Ziebuhr; Eric J Snijder
Journal:  Virus Res       Date:  2006-02-28       Impact factor: 3.303

View more
  30 in total

1.  A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins.

Authors:  Adriaan H de Wilde; Kazimier F Wannee; Florine E M Scholte; Jelle J Goeman; Peter Ten Dijke; Eric J Snijder; Marjolein Kikkert; Martijn J van Hemert
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

Review 2.  Host-Directed Antiviral Therapy.

Authors:  Naveen Kumar; Shalini Sharma; Ram Kumar; Bhupendra N Tripathi; Sanjay Barua; Hinh Ly; Barry T Rouse
Journal:  Clin Microbiol Rev       Date:  2020-05-13       Impact factor: 26.132

3.  Adaptive Mutations in Replicase Transmembrane Subunits Can Counteract Inhibition of Equine Arteritis Virus RNA Synthesis by Cyclophilin Inhibitors.

Authors:  Eric J Snijder; Clara C Posthuma; Adriaan H de Wilde; A Linda Boomaars-van der Zanden; Anja W M de Jong; Montserrat Bárcena
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

4.  A Recombinant Porcine Reproductive and Respiratory Syndrome Virus Stably Expressing a Gaussia Luciferase for Antiviral Drug Screening Assay and Luciferase-Based Neutralization Assay.

Authors:  Yanhua Li; Cicheng Ren; Chenxi Li; Yihong Xiao; Yanyang Zhou
Journal:  Front Microbiol       Date:  2022-05-13       Impact factor: 6.064

5.  Swine acute diarrhea syndrome coronavirus-induced apoptosis is caspase- and cyclophilin D- dependent.

Authors:  Jiyu Zhang; Yuru Han; Hongyan Shi; Jianfei Chen; Xin Zhang; Xiaobo Wang; Ling Zhou; Jianbo Liu; Jialin Zhang; Zhaoyang Ji; Zhaoyang Jing; Jingyun Ma; Da Shi; Li Feng
Journal:  Emerg Microbes Infect       Date:  2020-02-24       Impact factor: 7.163

6.  Cyclophilin A binds to the viral RNA and replication proteins, resulting in inhibition of tombusviral replicase assembly.

Authors:  Nikolay Kovalev; Peter D Nagy
Journal:  J Virol       Date:  2013-10-02       Impact factor: 5.103

Review 7.  Cyclophilins as modulators of viral replication.

Authors:  Stephen D Frausto; Emily Lee; Hengli Tang
Journal:  Viruses       Date:  2013-07-11       Impact factor: 5.048

8.  A novel porcine reproductive and respiratory syndrome virus vector system that stably expresses enhanced green fluorescent protein as a separate transcription unit.

Authors:  Chengbao Wang; Baicheng Huang; Ning Kong; Qiongyi Li; Yuping Ma; Zhijun Li; Jiming Gao; Chong Zhang; Xiangpeng Wang; Chao Liang; Lu Dang; Shuqi Xiao; Yang Mu; Qin Zhao; Yani Sun; Fernando Almazan; Luis Enjuanes; En-Min Zhou
Journal:  Vet Res       Date:  2013-10-31       Impact factor: 3.683

Review 9.  Suppression of coronavirus replication by cyclophilin inhibitors.

Authors:  Yoshikazu Tanaka; Yuka Sato; Takashi Sasaki
Journal:  Viruses       Date:  2013-05-22       Impact factor: 5.048

10.  Actinobacillus pleuropneumoniae possesses an antiviral activity against porcine reproductive and respiratory syndrome virus.

Authors:  Cynthia Lévesque; Chantale Provost; Josée Labrie; Yenney Hernandez Reyes; Jorge A Burciaga Nava; Carl A Gagnon; Mario Jacques
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.